Bio, you're getting under many skins today! I happen to agree with you on this however. This should be a pivotal week. Enjoy your positivity! Go MSTX!
Continuing to engage with SCD professionals and the SCD community. With all of the support they will be bringing a huge stack of letters and witnesses to the FDA ADCOM. Vepo is the first therapeutic for SCD and will be fast tracke through approval. The unmet need is great. The results will be overwhelmingly positive for quick approval and commercialization will begin very quickly.
We're so close to helping so many people in need.
God bless Mast and all it has done to dedicate itself to bringing Vepo to market.
She commented how excited she is for VEPO!
Profile photo of Lanetta Jordan
Lanetta Jordan on 03/04/2016 at 4:33 pm
Congratulations, MAST Therapeutics and the Sickle Cell Community! Indeed, a pivotal time in the history of Sickle Cell Disease. Although there are several remaining steps, the Foundation for Sickle Cell Disease is thrilled with the progress of the first therapeutic with an indication for Sickle Cell Disease. Lanetta Jordan, MD, MPH, MSPH, President
I'm going LOCK announced next week with a DATA release 2 weeks following. We should get up to near .50 before release and shoot past $2.00 upon release. Price will then go up and down similar to CPXX with climb above $3.00 within another week or two. guesses?
My feeling on the offering was that they wanted to give shares to board member and investor Lewis Shuster before the positive results. They know Sabby sells shares and keeps warrants so thy make the deal, Lewis quits the board, Sabby sells, Lewis buys, EPIC is positive and everyone becomes filthy rich. The only people who really lose are the ones (retail) who sold for a loss after the offering.
It's fantastic to have smart investors here who have done their homework. A pleasure to be with you
Have a great weekend all.
And go Mast!
Sentiment: Strong Buy
You really have joined at the perfect time! we should shoot past .30 today! The chart looks fantastic and we all know why. Have a great day!
We have a lot of news to be announced and this quarter is going to be quite epic. I believe we will start seeing filings of increased ownership by Baker Bros. look for that soon. Enjoy the day everyone. Off to sail.
Perhaps working on final touches on a press release in Pre Market? I would t be surprised, it's about time for some update(s). Vepo data lock and updated more defined timeline of release? AIR surprise of some kind? I think Culley knows full well he needs to spark this stock and get it moving pre-release. See you in the morning.
Update on EPIC results will be released at any moment as promised by Mr. Culley. Mast releases a PR stating a more fine tuned expected date of data release. Will come either today or Monday, in my opinion. Have a great weekend everyone!!
Sentiment: Strong Buy
Gang, it's been a long road. A bumpy road. A dark road at times. But if you just take share price out of the equation and just look at what has been accomplished by this company with Vepoloxamer, it's quite stunning and should be appreciated and celebrated today, the last day of the quarter. A huge, long, complicated trial that was designed for success has been successfully completed. The data is on the way. And we are about to see the first drug for SCD in generations. A disease that has caused so much pain and premature death to so many black people worldwide. Children especially affected. A disease that has sent hundreds of thousands of people to emergency rooms millions upon millions of times with no hope other than to ease the pain with addictive and harmful opioids. Vepoloxamer will ease pain and will help preserve organ function. It will become the standard of care for treating SCD episodes and will make the lives of patients instantly better and longer. I congratulate Culley and the team at Mast for getting this far. For putting on their blinders to the greedy investors and focusing on what is important. They have succeeded wildly. And tomorrow the second quarter begins and results could come at any time. It's going to be a fantastic year ahead and an even better 2017 as the FDA approves Vepoloxamer and it gets to patients. Culley and his team should be celebrated.
Hey All - Have you been adding under the offering price? I've been in a conference the past week and a half but have been adding here and there. Since the offering sliced us in half I've been adding to average down a bit and stand at just under 625,000 shares. Average still in the .38-.40 area.
I have agreed SABBY has been selling its shares and there have been some big buyers buying this up between .24 - .29. We are so close to various bits of news being released. I believe it could happen today or tomorrow leading into our long weekend.
We are about to explode folks. I truly believe there are several bits of news in ADDITION to EPIC that will get us moving. Then EPIC will push us up some 500-1000%.
It's been a long, difficult ride; but this kind of thing never comes easy. You have to have guts of steel to get through it. And then you shall be rewarded.
Those of us who have done our DD on this know very well the chances of EPIC success. And that's why I've invested so much money into it.
We're close. Very close.
Sentiment: Strong Buy
I'm seriously in awe of what Quick predicted with his Sabby share countdown. To the minute he was correct, taking into account the margin of error was exactly that. We are now set up to see a significant run into EPIC
Hey Quick - I have absolute confidence in the EPIC results. I still believe deep into my soul that results will be very positive, based on all of my years of due diligence, my listening to presentations, conference calls, of following Sickle Cell advocates and doctors and radio hosts who have discussed MST-188 (Vepoloxamer); based on my study of the science and of the preliminary assumptions, based on the patient in EPIC-e who has had three treatments unblinded, of knowing how Sabby invests, I could go on and on,
I am not worried as someone who has not done all of that work with the understanding I have. I am not concerned. We will do well. SCD patients will have a new treatment which will become standard of care.
This will be a fantastic story.
Only one more hurdle left, and this last one will be crossed quite easily as the runner has a jolt of adrenaline as he approaches the finish line.
Sentiment: Strong Buy